# Oncology Analytics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oncology-analytics

- Industry: Healthcare IT
- Headquarters: Atlanta, US
- Website: www.oncologyanalytics.com
- Total disclosed funding: $54M
- Latest round: Series C (Apr 30, 2020)
- Investors on record: 5

## About

Oncology Analytics, Inc. specializes in delivering advanced oncology management solutions that facilitate better cancer care by leveraging technology to navigate the complexities of treatment for patients, healthcare providers, and health organizations.Oncology Analytics, Inc. was founded in 2009 and is headquartered in Atlanta, US. The company focuses on providing integrated oncology management services. In May 2022, Arsenal Capital Partners and McKesson Corporation acquired a majority stake in the firm. Rick Dean is the CEO, and the company has successfully completed 4 funding rounds, with the most recent being a Series C round, raising USD 25.000 mn led by Baird Capital Partners. The total amount raised by the company stands at USD 25.000 mn, with a current valuation of USD 122.988 mn.Oncology Analytics, Inc. offers a comprehensive oncology management platform that integrates advanced software with technology-enabled services. This platform supports health plans, employers, oncologists, and patients in managing the varied challenges of cancer treatment, including 24/7 nursing support, mental health resources, and nutritional guidance. The company serves 18 health plans, impacting approximately 12 million members across the United States, and operates nationwide through a virtual medical group focused on oncology care.Oncology Analytics, Inc. generates revenue through subscription-based models and partnerships with healthcare organizations. Revenue is derived from service agreements with health plans and employers, allowing clients continuous access to their oncology management platform and services, which include digital care management. The contracts provide a recurring revenue stream, fundamental for the financial stability of the company.Oncology Analytics, Inc. aims to enhance its oncology-specific digital health solutions with the recent funding, slated to support innovation and improve delivery for patients. The company is also exploring expansion into new geographic markets, although specific regions have not been disclosed. The funding acquired in May 2022 will play a pivotal role in these initiatives, aligning with their strategic growth objectives.

## Funding rounds

- Series C, Apr 30, 2020, $25M — Baird Capital Partners, BlueCross BlueShield Venture Partners, McKesson Ventures, Oak HC/FT
- Series B, Nov 5, 2018, $21M — BlueCross BlueShield Venture Partners, Sandbox Industries, McKesson Ventures, Oak HC/FT
- Series A, Jan 13, 2016, $7.5M — BlueCross BlueShield Venture Partners, Sandbox Industries

## Investors

- BlueCross BlueShield Venture Partners (https://capitalatlas.ai/funds/bluecross-blueshield-venture-partners) — Series A, Series B, Series C
- Sandbox Industries (https://capitalatlas.ai/funds/sandbox-industries) — Series A, Series B
- McKesson Ventures (https://capitalatlas.ai/funds/mckesson-ventures) — Series B, Series C
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series B, Series C
- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series C